These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 27935090)

  • 1. Clinical utility of closure times using the platelet function analyzer-100/200.
    Favaloro EJ
    Am J Hematol; 2017 Apr; 92(4):398-404. PubMed ID: 27935090
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical utility of the PFA-100.
    Favaloro EJ
    Semin Thromb Hemost; 2008 Nov; 34(8):709-33. PubMed ID: 19214910
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical application of the PFA-100.
    Favaloro EJ
    Curr Opin Hematol; 2002 Sep; 9(5):407-15. PubMed ID: 12172459
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Utility of the PFA-100 for assessing bleeding disorders and monitoring therapy: a review of analytical variables, benefits and limitations.
    Favaloro EJ
    Haemophilia; 2001 Mar; 7(2):170-9. PubMed ID: 11260277
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The platelet function analyzer (PFA-100): an update on its clinical use.
    Franchini M
    Clin Lab; 2005; 51(7-8):367-72. PubMed ID: 16122146
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The platelet-function analyzer (PFA-100) for evaluating primary hemostasis.
    Franchini M
    Hematology; 2005 Jun; 10(3):177-81. PubMed ID: 16019466
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The utility of the PFA-100 in the identification of von Willebrand disease: a concise review.
    Favaloro EJ
    Semin Thromb Hemost; 2006 Jul; 32(5):537-45. PubMed ID: 16862528
    [TBL] [Abstract][Full Text] [Related]  

  • 8. External quality assessment/proficiency testing and internal quality control for the PFA-100 and PFA-200: an update.
    Favaloro EJ; Bonar R
    Semin Thromb Hemost; 2014 Mar; 40(2):239-53. PubMed ID: 24497116
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PFA-100 system: a new method for assessment of platelet dysfunction.
    Mammen EF; Comp PC; Gosselin R; Greenberg C; Hoots WK; Kessler CM; Larkin EC; Liles D; Nugent DJ
    Semin Thromb Hemost; 1998; 24(2):195-202. PubMed ID: 9579642
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Laboratory monitoring of therapy in von Willebrand disease: efficacy of the PFA-100 and von Willebrand factor:collagen-binding activity as coupled strategies.
    Favaloro EJ
    Semin Thromb Hemost; 2006 Sep; 32(6):566-76. PubMed ID: 16977567
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PFA-100 test in the detection of platelet dysfunction and monitoring DDAVP in a patient with liver cirrhosis undergoing inguinal hernia repair.
    Vucelić D; Golubović M; Bjelović M
    Srp Arh Celok Lek; 2012; 140(11-12):782-5. PubMed ID: 23350257
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of the PFA-100 in the assessment of primary, platelet-related hemostasis in a pediatric setting.
    Rand ML; Carcao MD; Blanchette VS
    Semin Thromb Hemost; 1998; 24(6):523-9. PubMed ID: 10066147
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Potential supplementary utility of combined PFA-100 and functional von Willebrand factor testing for the laboratory assessment of desmopressin and factor concentrate therapy in von Willebrand disease.
    Favaloro EJ; Thom J; Patterson D; Just S; Baccala M; Dixon T; Meiring M; Koutts J; Rowell J; Baker R
    Blood Coagul Fibrinolysis; 2009 Sep; 20(6):475-83. PubMed ID: 19584715
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of PFA-100 testing and bleeding time for detecting platelet hypofunction and von Willebrand disease in clinical practice.
    Posan E; McBane RD; Grill DE; Motsko CL; Nichols WL
    Thromb Haemost; 2003 Sep; 90(3):483-90. PubMed ID: 12958618
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [New in vitro analysis tested: bleeding time is still the best method for evaluation of primary hemostasis].
    Ridefelt P; Egberg N; Hillarp A; Lethagen S; Tengborn L
    Lakartidningen; 2001 Sep; 98(37):3922-4. PubMed ID: 11586831
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diagnostic performance of the platelet function analyzer (PFA-100) for the detection of disorders of primary haemostasis in patients with a bleeding history-a systematic review and meta-analysis.
    Karger R; Donner-Banzhoff N; Müller HH; Kretschmer V; Hunink M
    Platelets; 2007 Jun; 18(4):249-60. PubMed ID: 17538845
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessment of primary hemostasis by PFA-100 analysis in a tertiary care center.
    Ortel TL; James AH; Thames EH; Moore KD; Greenberg CS
    Thromb Haemost; 2000 Jul; 84(1):93-7. PubMed ID: 10928477
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Time for a conceptual shift in assessment of internal quality control for whole blood or cell-based testing systems? An evaluation using platelet function and the PFA-100 as a case example.
    Favaloro EJ
    Clin Chem Lab Med; 2013 Apr; 51(4):767-74. PubMed ID: 23152413
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Utility of the PFA-100 as a screening test of platelet function: an audit of haemostasis laboratories in Australia and New Zealand.
    Favaloro EJ; Bonar R; Duncan E; Rodgers S; Marsden K;
    Blood Coagul Fibrinolysis; 2007 Jul; 18(5):441-8. PubMed ID: 17581318
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Template bleeding time and PFA-100 have low sensitivity to screen patients with hereditary mucocutaneous hemorrhages: comparative study in 148 patients.
    Quiroga T; Goycoolea M; Muñoz B; Morales M; Aranda E; Panes O; Pereira J; Mezzano D
    J Thromb Haemost; 2004 Jun; 2(6):892-8. PubMed ID: 15140124
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.